SPIN is steered by a Scientific Committee that supervises the good development of the Psoriasis International Network. The coordinators of the Scientific Committee represent the committee within the FRT - Fondation Rene Touraine’s Scientific Board.
The mission of the SPIN Committee is to develop the activities of the network, in particular by proposing international collaborative projects, contributing to continuing medical training in the field of skin inflammation and providing support to the development of national and regional networks.
Coordinators of SPIN Scientific Committee
-
-
President-elect
Phyllis SPULSMD, PhD, Consultant Dermatologist at The Academic Medical Centre of the University of Amsterdam, NL
-
Past-president
Luigi NALDIDirector of Centro Studi GISED, Fondazione per la Ricerca Ospedale Maggiore, Bergamo, Italy
-
President FRT Scientific Board
Luis PUIGMD, PhD, Department of Dermatology, Hospital de la Sanat Creu i Sant Pau, Barcelona, Spain
-
Past-President FRT Scientific Board
Thomas LUGERChair of Department of Dermatology, University of Münster, Germany
Members of the committee (by alphabetical order)
Martine BAGOT
Professor and Chairperson, Dermatology Department and INSERM U976, Hôpital Saint Louis, Paris, France
José Manuel CARRASCOSA
Associate Professor Department of Dermatology, Universitary Hospital Germans Trias I Pujol, Badalona, Spain
Romana CEOVIC
MD, PhD, University Department of Dermatovenerology, Zagreb Clinical Hospital and School of Medicine, Zagreb, Croatia
Elke DE JONG
Dermatologist at University Medical Center Nijmegen St Radboud, The Netherlands
Nejib DOSS
Head of the department of Dermatology – Military Hospital of Tunis, Professor Faculty of Medicine Tunis, Tunisia
Emad ELGAMAL
Professor of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, New Damietta, Egypt
Carsten FLOHR
Professor Carsten Flohr, chair in dermatology and population science, St
John’s Institute of Dermatology, King’s college london
Maria Lorna FREZ
MD, Professor in Dermatology, University of the Philippines College of Medicine – Philippine General Hospital, Philippines
Giampiero GIROLOMONI
Professor of Dermatology and Head of the Dermatology Section in the Department of Medicine at the University of Verona School of Medicine, Verona, Italy
César GONZALEZ
Coordinator Grupo Colombiano de Psoriasis y artritis psoriasica (CoLPsor), Colombia
Alice GOTTLIEB
MD, PhD, Chair of Dermatology, Tufts Medical Centre, Boston, Massachusetts, USA
Christopher EM GRIFFITHS
MD FRCP FMedSci, Professor of Dermatology, The University of Manchester, Manchester Academic Health Science Centre, The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, UK
Jan Gutermuth
Professor Jan Gutermuth studied medicine at the Johannes Gutenberg-University Mainz/ Germany and trained in dermatology and allergology at the Humboldt University Berlin (Charité) and Technische University Munich (TUM).
Rolland GYULAI
MD, PhD, Director and chair of the Department of Dermatology, Venerology and Dermatooncology, University of Pécs, Hungary
Kenji KABASHIMA
Pr. Kenji KABASHIMA, Chairman and Head, Department of Dermatology, Kyoto University Graduate School of Medicine, Japan.
Lajos KEMENY
Professor and Chair of the Department of Dermatology and Allergology, University of Szeged, Hungary
Alur S. KUMAR
Professor and Head of Department, Owaisi Hospital Deccan College of Medical Sciences, Hyderabad, India
Richard LANGLEY
MD, FRCPC, Professor of Medicine (Dermatology) and Director of Research, Division of Dermatology, Department of Medicine, Dalhousie University, Canada
Mark LEBWOHL
MD, Sol and Clara Kest Professor and Chairman, Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY, USA
Fatimata LY
Head of the Dermatology Department at the Institute of Social Hygiene in Dakar, Professor of Dermatology at the University Cheikh Anta Diop of Dakar, Senegal
Alan MENTER
Chair of research for Dermatology at Baylor Research Institute, Clinical Professor of Dermatology at the University of Texas Southwestern Medical School in Dallas and Professor at Texas A&M Health Science Center, College of Medicine, USA
Ulrich MROWIETZ
MD, Head of Psoriasis-Center, Dept. of Dermatology, Venerology and Allergology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany
Alexander NAST
Department of Dermatology, Venerology and Allergy, Charité – Universitätsmedizin Berlin, Germany
Carle PAUL
Chair of Department of Dermatology, Paul Sabatier University, CHU Larrey, Toulouse, France
Jörg Christoph PRINZ
Univ.-Prof. Dr. med. Univ. Jörg Christoph PRINZ, Clinic for Dermatology and Allergology, Ludwig-Maximilians-University, Munich, Germany
Nélida RAIMONDO
Head of the Department of Dermatology, Air Force Hospital Buenos Aires, Titular Professor of Dermatology at University Maimónides, Buenos Aires, President of the Latin American Society of Psoriasis (SOLAPSO), Argentina
Kristian REICH
Professor of Dermatology at the Georg-August-University Göttingen and at the Dermatologikum Berlin in Germany
Hugo SCHONENBERGER DE OLIVEIRA
MD University Dermatology Clinic, Coimbra University Hospital, Portugal
Lone SKOV
Professor, Consultant, Department of Dermato-Allergology, Gentofte Hospital,
Faculty of Health Sciences, University of Copenhagen, Denmark
Mona STAHLE
Professor of Dermatology and Venereology, Department of Medicine, Solna Karolinska Institute, Stockholm, Sweden
Diamant THAÇI
Professor and Head Comprehensive Center for Inflammation Medicine, University Luebeck, Germany
Jacob THYSSEN
Dr Thyssen is a clinical dermatologist and Professor employed by the
Capital Region and University of Copenhagen in Denmark.
Skaidra VALIUKEVICIENE
Professor and Head of the Department of Skin and Venereal Diseases, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
Peter VAN DE KERKHOF
Chief of the Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands
Christian VESTERGAARD
Aarhus University Hospital | AUH · Department of Dermatology
Richard WARREN
NIHR Clinical Senior Lecturer in Dermatology, Dermatology Centre, University of Manchester, Honorary Consultant Dermatologist Salford Royal NHS Foundation Trust, Manchester, UK
ZHENG Min
Professor and Chairman of the Department of Dermatology at Zhejiang University School of Medicine, China
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Arch. Dermatol. Res..
2020 May , 312, (4):249-253.
Narrow-band ultraviolet B (NB-UVB) phototherapy is an effective and widely used treatment modality for psoriasis and other inflammatory skin diseases. The carcinogenic effect of PUVA treatment has been investigated extensively, but there is very scarce data about the role of NB-UVB in the development of skin cancer. The aim of this study was to investigate the potential carcinogenic risk of NB-UVB therapy in various skin disorders. In this cross-sectional study, we evaluated 100 patients (...)
see on pubmed
A potential association between psoriasin to rs4819554 of IL-17RA gene polymorphism in psoriasis Egyptian patients.
Arch. Dermatol. Res..
2020 May , 312, (4):273-281.
Interleukin 17 (IL-17) is one of the pro-inflammatory cytokine. Psoriasin is a noticeably over-expressed protein found in the skin lesions of psoriatic patients. Our current study was planned to examine the association of (- 947 A/G) single nucleotide polymorphism (SNP) in IL-17RA promoter region (rs4819554) with psoriasis susceptibility in Egyptian psoriatic patients. Our study included 100 patients and 100, age as well as sex matched, control groups. IL-17RA SNP association was studied (...)
see on pubmed
Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation.
J. Cell. Physiol..
2020 Jun , 235, (6):5270-5283.
Drug discovery is an onerous, extremely expensive, and time-consuming process. Instead, drug repurposing is an attractive strategy for exploiting novel indications for a drug beyond its original use. The untapped potential of drug repurposing compensates the barriers associated with the drug discovery pipeline. Psoriasis is an autoimmune skin disease, where hyperproliferation of keratinocytes and exaggerated immune responses are the important hallmarks of the disease. Extensive in vitro and (...)
see on pubmed
on Atopic Dermatitis
Drug delivery system of dual-responsive PF127 hydrogel with polysaccharide-based nano-conjugate for textile-based transdermal therapy.
Carbohydr Polym.
2020 May 15, 236:116074.
Pluronic F-127 based dual-responsive (pH/temperature) hydrogel drug delivery system was developed involving polysaccharide-based nano-conjugate of hyaluronic acid and chitosan oligosaccharide lactate and applied for loading of gallic acid which is the principal component of traditional Chinese medicine Cortex Moutan recommended in the treatment of atopic dermatitis. The polysaccharide-based nano-conjugate was used as pH-responsive compound in the formulation and its amphiphilic character (...)
see on pubmed
Skin of atopic dermatitis patients shows disturbed β-glucocerebrosidase and acid sphingomyelinase activity that relates to changes in stratum corneum lipid composition.
Biochim Biophys Acta Mol Cell Biol Lipids.
2020 Jun , 1865, (6):158673.
Patients with Atopic Dermatitis (AD) suffer from inflamed skin and skin barrier defects. Proper formation of the outermost part of the skin, the stratum corneum (SC), is crucial for the skin barrier function. In this study we analyzed the localization and activity of lipid enzymes β-glucocerebrosidase (GBA) and acid sphingomyelinase (ASM) in the skin of AD patients and controls. Localization of both the expression and activity of GBA and ASM in the epidermis of AD patients was altered, (...)
see on pubmed
Physiology and Pathophysiology of Itch.
Cevikbas F et al.
Physiology and Pathophysiology of Itch.
Physiol. Rev..
2020 Jul 01, 100, (3):945-982.
Itch is a topic to which everyone can relate. The physiological roles of itch are increasingly understood and appreciated. The pathophysiological consequences of itch impact quality of life as much as pain. These dynamics have led to increasingly deep dives into the mechanisms that underlie and contribute to the sensation of itch. When the prior review on the physiology of itching was published in this journal in 1941, itch was a black box of interest to a small number of neuroscientists (...)
see on pubmed
